Written by the Nuvirox Research Team
Short answer: the mechanistic connection between NAD+ and thyroid-driven metabolism is real, but there are currently no published human trials testing NAD+ precursors specifically for thyroid function. This is one of the more honest "not yet studied" gaps in the NAD+ research landscape.
Key Points
- Thyroid hormone regulates mitochondrial activity and metabolic rate — the same cellular machinery that depends on NAD+.
- No published human trial has tested nicotinamide riboside or NMN specifically for thyroid hormone levels, hypothyroidism, or hyperthyroidism.
- At least one major NAD+ precursor trial specifically excluded people with uncontrolled thyroid disease, underscoring that thyroid status is treated as a confound to control for, not a study endpoint.
Why people ask this question
Both hypothyroidism and low NAD+ status share a strikingly similar symptom fingerprint: fatigue, cold intolerance, brain fog, slow metabolism, and low exercise tolerance. That overlap is exactly why the question comes up so often — if NAD+ decline can mimic some thyroid symptoms, does raising NAD+ actually help thyroid function, or does it just treat some of the same downstream symptoms through a completely separate pathway?
The real mechanism: mitochondria, not the thyroid gland itself
Thyroid hormone (specifically T3) is one of the body's primary regulators of mitochondrial biogenesis — it tells your cells how many mitochondria to build and how hard to run them, which is a major determinant of resting metabolic rate. NAD+ is the coenzyme those same mitochondria depend on for oxidative phosphorylation, the process that actually generates ATP. In other words, thyroid hormone sets the metabolic "dial," and NAD+ is one of the resources the mitochondria need to respond to that dial setting.
This means the mechanistic story runs through shared mitochondrial machinery, not through any known effect of NAD+ precursors on the thyroid gland, TSH, T3, or T4 production. There is no established biological pathway by which taking NR or NMN would be expected to directly raise or lower thyroid hormone levels.
What the human trial record actually shows
Searching the published NAD+ precursor trial literature turns up no studies with thyroid function, TSH, T3, T4, or hypothyroidism as a primary or secondary outcome. That's a real evidence gap, not a subtle one. If anything, the record shows the opposite emphasis: a landmark 2018 crossover trial of nicotinamide riboside in healthy middle-aged and older adults specifically excluded participants with uncontrolled thyroid disease from enrollment, alongside people with abnormal kidney or liver function [1]. Researchers treat thyroid status as a variable to control for so it doesn't confound their other measurements — not as something they're testing NAD+ precursors against.
What NAD+ won't do
NAD+ precursors are not a treatment for hypothyroidism, Hashimoto's thyroiditis, hyperthyroidism, or any other thyroid condition, and nothing in the current research supports using them that way. If you have symptoms consistent with a thyroid problem — unexplained weight change, persistent fatigue, cold intolerance, hair thinning, heart rate changes — the appropriate first step is bloodwork (TSH, free T4, and often free T3) with your doctor, not a supplement trial. Thyroid disorders are diagnosable and highly treatable with standard medical care; guessing at the cause with supplements can delay that diagnosis.
Where NAD+ precursors might reasonably fit
If your thyroid labs come back normal and you're still dealing with low energy, that's a different — and better-studied — question. NAD+'s more established human evidence base is around general cellular energy metabolism and mitochondrial function in aging adults, not thyroid-specific effects. That's a meaningfully different claim, and one worth being precise about.
Frequently asked questions
Can NAD+ supplements help with hypothyroidism?
There's no evidence for this. No human trial has tested NAD+ precursors for thyroid function, and there's no known mechanism by which they'd affect TSH, T3, or T4 production directly.
Why do NAD+ decline and hypothyroidism feel so similar?
Both can produce fatigue, cold intolerance, and brain fog because both affect mitochondrial energy output — but through separate pathways. Thyroid hormone sets metabolic rate; NAD+ is a resource mitochondria need to meet that rate.
Should I get my thyroid tested before trying NAD+ supplements?
If you have symptoms that could be thyroid-related — unexplained fatigue, weight change, cold intolerance — yes, talk to your doctor about thyroid bloodwork first. It's a fast, definitive way to rule a real medical cause in or out.
Is it safe to take NAD+ precursors alongside thyroid medication like levothyroxine?
There's no published research on this specific interaction. If you're on thyroid medication, check with your doctor or pharmacist before adding a new supplement.
If your interest here is really about low energy rather than the thyroid gland specifically, our broader look at NAD+ and metabolism covers the better-studied blood sugar and metabolic-rate research, and why energy drops in your 40s digs into the cellular aging side of that question. For the psychological and HPA-axis side of energy and fatigue, see our companion piece on NAD+ and stress resilience.
Can low thyroid function actually cause NAD+ to decline, rather than the other way around?
This hasn't been directly studied. Thyroid hormone regulates mitochondrial activity broadly, so it's plausible that thyroid status could influence NAD+-dependent processes indirectly, but no trial has measured this specific relationship in either direction.
It’s also worth noting how thyroid status typically gets handled across the broader NAD+ precursor trial literature: it’s consistently treated as an exclusion criterion rather than a study variable. The landmark 2018 Martens trial excluded people with uncontrolled thyroid disease specifically so that thyroid-driven metabolic differences wouldn’t confound the vascular and NAD+ metabolome outcomes researchers were actually trying to measure. That’s a useful signal: researchers view thyroid function as a separate biological system that needs to be controlled for, not a system they expect their intervention to change. If you have a diagnosed thyroid condition and are already on treatment (like levothyroxine), your endocrinologist is best positioned to interpret how any new supplement might fit into your broader picture — general population trial data doesn’t map cleanly onto managed thyroid disease.
From Nuvirox
Why we formulated NAD+ Restore
If what you're dealing with sounds like it belongs in a doctor's office rather than a supplement aisle, please start there — a clinician can rule out the specific causes discussed above. For general cellular energy support, each serving of NAD+ Restore provides 500 mg of nicotinamide riboside chloride (NR), one of the two most-researched NAD+ precursors, within the dose range used in published human trials, alongside 150 mg trans-resveratrol and 50 mg quercetin (polyphenols studied alongside NAD+ pathways for cellular health support) and 10 mg of galactomannans from fenugreek to support absorption.
We back it with a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
Learn more about NAD+ Restore →The bottom line
This is one of the more honest gaps in NAD+ research: the mitochondrial mechanism connecting NAD+ to metabolic rate is well established, and thyroid hormone happens to regulate that same mitochondrial machinery — but no trial has actually tested whether NAD+ precursors affect thyroid function itself. If you suspect a thyroid issue, get it checked; if your thyroid is healthy and you're still fatigued, that's a separate, better-studied conversation about cellular energy support.
References
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286. doi:10.1038/s41467-018-03421-7.
- Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Rep. 2019;28(7):1717-1728. PMCID: PMC6702140.
- Damgaard MV, Treebak JT. What is really known about the effects of nicotinamide riboside supplementation in humans. Sci Adv. 2023;9. doi:10.1126/sciadv.adi4862.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.